Histogen (HSTO) Competitors $0.04 0.00 (0.00%) As of 07/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock HSTO vs. AMPE, EFTR, ONCSQ, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, and ARAVShould you be buying Histogen stock or one of its competitors? The main competitors of Histogen include Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), and ARAVIVE (ARAV). These companies are all part of the "pharmaceutical products" industry. Histogen vs. Its Competitors Ampio Pharmaceuticals eFFECTOR Therapeutics OncoSec Medical PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech ARAVIVE Ampio Pharmaceuticals (NYSE:AMPE) and Histogen (NASDAQ:HSTO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Which has more risk and volatility, AMPE or HSTO? Ampio Pharmaceuticals has a beta of 4.76, meaning that its stock price is 376% more volatile than the S&P 500. Comparatively, Histogen has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Do institutionals & insiders believe in AMPE or HSTO? 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Comparatively, 3.3% of Histogen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is AMPE or HSTO more profitable? Company Net Margins Return on Equity Return on Assets Ampio PharmaceuticalsN/A N/A N/A Histogen N/A N/A N/A Which has preferable earnings and valuation, AMPE or HSTO? Ampio Pharmaceuticals has higher earnings, but lower revenue than Histogen. Histogen is trading at a lower price-to-earnings ratio than Ampio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00Histogen$19K7.89-$10.62M-$2.81-0.01 Does the media favor AMPE or HSTO? In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled Histogen'saverage media sentiment score. Company Overall Sentiment Ampio Pharmaceuticals Neutral Histogen Neutral SummaryAmpio Pharmaceuticals beats Histogen on 4 of the 6 factors compared between the two stocks. Get Histogen News Delivered to You Automatically Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSTO vs. The Competition Export to ExcelMetricHistogenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$150K$753.22M$5.51B$9.31BDividend YieldN/A4.84%4.25%4.09%P/E Ratio-0.011.4328.1819.72Price / Sales7.8925.51439.19110.06Price / CashN/A19.5635.5357.53Price / Book0.016.608.235.67Net Income-$10.62M-$4.53M$3.23B$257.51M7 Day PerformanceN/A0.25%-0.61%-0.16%1 Month PerformanceN/A1.56%6.63%9.89%1 Year PerformanceN/A-0.43%27.07%15.08% Histogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSTOHistogenN/A$0.04flatN/A-83.3%$150K$19K-0.0120AMPEAmpio PharmaceuticalsN/A$0.00-32.5%N/A-88.9%$3KN/A0.0020Gap DownEFTReFFECTOR Therapeutics0.0786 of 5 stars$0.00-33.3%N/AN/A$1KN/A0.0010Gap DownONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040PXMDPaxMedica0.1414 of 5 stars$0.00flatN/A-100.0%$1KN/A0.002ATNFW180 Life SciencesN/A$0.01-4.8%N/A-25.0%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01-22.0%N/AN/A$0.00N/A0.002AIMDWAinosN/A$0.12+0.2%N/A+121.1%$0.00$106.21K0.0040Gap DownALVOWAlvotechN/A$1.93+1.6%N/A-28.0%$0.00$585.60M0.004ARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading Volume Related Companies and Tools Related Companies Ampio Pharmaceuticals Competitors eFFECTOR Therapeutics Competitors OncoSec Medical Competitors PaxMedica Competitors 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors ARAVIVE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSTO) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
